EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Survival Heterogeneity in U.S. Hospice Patients: A Retrospective Cohort Study

Ian Duncan iD, Xiyue Liao iD, Terri Maxwell

American Journal of Hospice and Palliative Medicine® · 29.06.2026

DOI: 10.1177/10499091261462816 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift American Journal of Hospice and Palliative Medicine®, online erschienen am 29.06.2026. Verfasst von Ian Duncan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics & Applied Probability, University of California Santa Barbara, Santa Barbara, CA, USA. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hospice has become an important component of End-of-life care in the United States. The use of hospice, however, remains subject to many forces, including the patient, providers, families and cultural beliefs. One consequence of these forces is significant variability of survival of patients in hospice. In a recent study, the authors reported a median survival of approximately 24 days after enrollment. However, a significant minority of patients survive for more than 180 days (the target set by CMS for the Medicare hospice benefit). We examine the factors contributing to the variability of hospice patient survival, including demographics, diagnoses, care setting, and patient drug prescriptions. We apply Cox proportional hazards models to assess the effect of covariates on time-to-event (in this case death in hospice). A high hazard ratio is associated with a shorter life expectancy. In addition to these factors we evaluated medication exposure variables. Medications are strongly associated with the mortality hazard: analgesic use is associated with a nearly three-fold higher hazard (HR = 2.977), and anxiolytic use with a roughly two-fold higher hazard (HR = 1.910) when compared with the group without any anxiolytic use. We provide a detailed understanding of medication use near the end of life that serve as an indicator that medication trajectories can serve as an additional indicator of symptom burden and individualized care planning.

Schlagwörter

Stichwörter der Autor:innen

Analgesic useAnxiolytic useCox Proportional HazardsEnd-of-lifePalliative DrugsSurvival probability

Autor:innen und Institutionen

  • Department of Statistics & Applied Probability, University of California Santa Barbara, Santa Barbara, CA, USA.
  • Department of Mathematics & Statistics, California State University San Diego, San Diego, CA, USA.
  • TLM Health Solutions, Philadelphia, PA, USA.

ORCID-Profile: Ian Duncan, Xiyue Liao

Zitieren

APA

Duncan, I., Liao, X., & Maxwell, T. (2026). Survival Heterogeneity in U.S. Hospice Patients: A Retrospective Cohort Study. American Journal of Hospice and Palliative Medicine®. https://doi.org/10.1177/10499091261462816

Vancouver

Duncan I, Liao X, Maxwell T. Survival Heterogeneity in U.S. Hospice Patients: A Retrospective Cohort Study. American Journal of Hospice and Palliative Medicine®. 2026. doi:10.1177/10499091261462816

BibTeX
@article{Duncan2026,
  author = {Duncan, Ian and Liao, Xiyue and Maxwell, Terri},
  title = {Survival Heterogeneity in U.S. Hospice Patients: A Retrospective Cohort Study},
  journal = {American Journal of Hospice and Palliative Medicine®},
  year = {2026},
  doi = {10.1177/10499091261462816}
}
Kostenlos starten →